Potential molecular therapeutic target for canine HSA

“The expression of RTKs, c-kit, VEGFR-2 and PDGFR-2, as well as PI3K/Akt/m-TOR and MEK was higher in canine splenic HSAs compared to normal spleens. These proteins may therefore be potential therapeutic targets in canine splenic HSA.”

Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma